STOCK TITAN

Harris Associates Discloses 6.8% Stake in IQVIA via Schedule 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Harris Associates L.P. and Harris Associates, Inc. filed an Amendment No. 1 to Schedule 13G reporting beneficial ownership of IQVIA Holdings Inc. common stock. The filing shows an aggregate of 11,753,182 shares, representing 6.8% of the class, with sole voting power over 10,291,782 shares and sole dispositive power over 11,753,182 shares. The Schedule identifies IQVIA's principal executive office at 2400 Ellis Road, Durham, NC.

The statement notes the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The filing is dated as an event on 06/30/2025 and signed on 08/14/2025 by Joseph J. Allessie as General Counsel and Secretary.

Positive

  • Clear disclosure of beneficial ownership: aggregate 11,753,182 shares reported
  • Material stake quantified: represents 6.8% of the class
  • Specified voting/dispositive powers: sole voting power 10,291,782, sole dispositive power 11,753,182
  • Certification of passive intent: securities held in the ordinary course and not to influence control

Negative

  • None.

Insights

TL;DR: Harris reports a meaningful passive stake of 6.8% with sole dispositive authority, disclosed via a Schedule 13G/A.

Harris Associates reports beneficial ownership of 11.75 million IQVIA shares, equivalent to 6.8% of outstanding common stock, and retains sole dispositive power for those shares. The Schedule 13G/A framework and the certification language indicate a passive investment held in the ordinary course of business rather than an activist or control-seeking position. Key metrics—aggregate shares, percent ownership, and voting/dispositive splits—are clearly stated and allow investors to quantify Harris’s economic exposure and voting influence.

TL;DR: Filing signals a significant institutional stake but affirms non-control intent under Schedule 13G rules.

The filing shows Harris Associates as an investment adviser/parent entity with sole voting power over ~10.29 million shares and sole dispositive power over ~11.75 million shares. The certification explicitly states the securities were not acquired to change or influence issuer control, consistent with passive investor treatment under Schedule 13G. From a governance perspective, this disclosure improves transparency about a large shareholder yet does not, per the filing, indicate plans to engage in governance actions.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



HARRIS ASSOCIATES L P
Signature:Joseph J. Allessie
Name/Title:Joseph J. Allessie, General Counsel and Secretary
Date:08/14/2025
Harris Associates, Inc.
Signature:Joseph J. Allessie
Name/Title:Joseph J. Allessie, General Counsel and Secretary
Date:08/14/2025

FAQ

How many IQV (IQVIA) shares does Harris Associates report owning?

Harris Associates reports beneficial ownership of 11,753,182 shares of IQVIA common stock.

What percentage of IQV's class does Harris Associates' holding represent?

The filing reports that the stake represents 6.8% of the class.

How much voting power does Harris Associates have over IQV shares?

The filing shows sole voting power over 10,291,782 shares and sole dispositive power over 11,753,182 shares.

Was the Schedule 13G/A filed as an amendment and when was it signed?

Yes; it is labeled Amendment No. 1 and the signature date is 08/14/2025.

Does the filing state Harris Associates intends to influence control of IQVIA?

No; the certification states the shares were acquired and are held in the ordinary course of business and not to change or influence control.
Iqvia Hldgs Inc

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Latest SEC Filings

IQV Stock Data

28.31B
167.90M
1.05%
102.1%
2.9%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
DURHAM